APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coronary Stents

Coronary stent is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Coronary stent is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease.

Selected research

Market Outlook & Growth Opportunities

Global Coronary Stents Market Outlook and Growth Opportunities 2026

26 December 2025190 pages

Choose your research edition.

Industry ResearchCoronary Stents Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Coronary Stents Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Coronary Stents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coronary Stents Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Coronary Stents Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Coronary stent is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease.

North America is the largest producer, with a market share nearly 70%. Abbott Vascular, Medtronic and Boston Scientific are the top 3 players of Coronary Stents market, and they had a nearly 70% combined market share.

This report provides an overview of the global Coronary Stents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Coronary Stents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Coronary Stents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Coronary Stents market size, projected growth trends, production technologies, key applications, and end-use industries.

Coronary Stents Segment by Company

Medtronic

Boston Scientific

Biosensors

Terumo

MicroPort

Lepu Medical

B.Braun

Atrium Medical

SINOMED

LBC

Essen Technology

Coronary Stents Segment by Type

Bare-metal Stent (BMS)

Drug-eluting Stent (DES)

Bioresorbable Vascular Scaffold (BVS)

Coronary Stents Segment by Application

ASCs

Hospitals

Cardiology Center

Coronary Stents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Coronary Stents status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Coronary Stents market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Coronary Stents significant trends, drivers, influence factors in global and regions.

6. To analyze Coronary Stents competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coronary Stents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coronary Stents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coronary Stents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Coronary Stents market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Coronary Stents industry.

Chapter 3: Detailed analysis of Coronary Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Coronary Stents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Coronary Stents in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Coronary Stents Industry Trends Table 2. Coronary Stents Industry Drivers Table 3. Coronary Stents Industry Opportunities and Challenges Table 4. Coronary Stents Industry Restraints Table 5. Global Coronary Stents Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Coronary Stents Revenue Share by Company (2021-2026) Table 7. Global Coronary Stents Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Coronary Stents Sales Volume Share by Company (2021-2026) Table 9. Global Coronary Stents Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Coronary Stents Company Ranking, (2024-2026) & (USD Million) Table 11. Global Coronary Stents Key Company Manufacturing Base & Headquarters Table 12. Global Coronary Stents Company, Product Type & Application Table 13. Global Coronary Stents Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Coronary Stents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Bare-metal Stent (BMS) Table 18. Significant Companies of Drug-eluting Stent (DES) Table 19. Significant Companies of Bioresorbable Vascular Scaffold (BVS) Table 20. Global Coronary Stents Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Coronary Stents Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Coronary Stents Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Coronary Stents Sales Volume Share by Type (2021-2026) Table 24. Global Coronary Stents Sales Volume Share by Type (2027-2032) Table 25. Global Coronary Stents Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Coronary Stents Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Coronary Stents Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Coronary Stents Sales Value Share by Type (2021-2026) Table 29. Global Coronary Stents Sales Value Share by Type (2027-2032) Table 30. Significant Companies of ASCs Table 31. Significant Companies of Hospitals Table 32. Significant Companies of Cardiology Center Table 33. Global Coronary Stents Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Coronary Stents Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Coronary Stents Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Coronary Stents Sales Volume Share by Application (2021-2026) Table 37. Global Coronary Stents Sales Volume Share by Application (2027-2032) Table 38. Global Coronary Stents Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Coronary Stents Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Coronary Stents Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Coronary Stents Sales Value Share by Application (2021-2026) Table 42. Global Coronary Stents Sales Value Share by Application (2027-2032) Table 43. Global Coronary Stents Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Coronary Stents Sales by Region (2021-2026) & (K Units) Table 45. Global Coronary Stents Sales Market Share by Region (2021-2026) Table 46. Global Coronary Stents Sales by Region (2027-2032) & (K Units) Table 47. Global Coronary Stents Sales Market Share by Region (2027-2032) Table 48. Global Coronary Stents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Coronary Stents Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Coronary Stents Sales Value Share by Region (2021-2026) Table 51. Global Coronary Stents Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Coronary Stents Sales Value Share by Region (2027-2032) Table 53. Global Coronary Stents Market Average Price (USD/Unit) by Region (2021-2026) Table 54. Global Coronary Stents Market Average Price (USD/Unit) by Region (2027-2032) Table 55. Global Coronary Stents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Coronary Stents Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Coronary Stents Sales by Country (2021-2026) & (K Units) Table 58. Global Coronary Stents Sales Market Share by Country (2021-2026) Table 59. Global Coronary Stents Sales by Country (2027-2032) & (K Units) Table 60. Global Coronary Stents Sales Market Share by Country (2027-2032) Table 61. Global Coronary Stents Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Coronary Stents Sales Value Market Share by Country (2021-2026) Table 63. Global Coronary Stents Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Coronary Stents Sales Value Market Share by Country (2027-2032) Table 65. Medtronic Company Information Table 66. Medtronic Business Overview Table 67. Medtronic Coronary Stents Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 68. Medtronic Coronary Stents Product Portfolio Table 69. Medtronic Recent Development Table 70. Boston Scientific Company Information Table 71. Boston Scientific Business Overview Table 72. Boston Scientific Coronary Stents Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 73. Boston Scientific Coronary Stents Product Portfolio Table 74. Boston Scientific Recent Development Table 75. Biosensors Company Information Table 76. Biosensors Business Overview Table 77. Biosensors Coronary Stents Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 78. Biosensors Coronary Stents Product Portfolio Table 79. Biosensors Recent Development Table 80. Terumo Company Information Table 81. Terumo Business Overview Table 82. Terumo Coronary Stents Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 83. Terumo Coronary Stents Product Portfolio Table 84. Terumo Recent Development Table 85. MicroPort Company Information Table 86. MicroPort Business Overview Table 87. MicroPort Coronary Stents Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. MicroPort Coronary Stents Product Portfolio Table 89. MicroPort Recent Development Table 90. Lepu Medical Company Information Table 91. Lepu Medical Business Overview Table 92. Lepu Medical Coronary Stents Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. Lepu Medical Coronary Stents Product Portfolio Table 94. Lepu Medical Recent Development Table 95. B.Braun Company Information Table 96. B.Braun Business Overview Table 97. B.Braun Coronary Stents Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. B.Braun Coronary Stents Product Portfolio Table 99. B.Braun Recent Development Table 100. Atrium Medical Company Information Table 101. Atrium Medical Business Overview Table 102. Atrium Medical Coronary Stents Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Atrium Medical Coronary Stents Product Portfolio Table 104. Atrium Medical Recent Development Table 105. SINOMED Company Information Table 106. SINOMED Business Overview Table 107. SINOMED Coronary Stents Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. SINOMED Coronary Stents Product Portfolio Table 109. SINOMED Recent Development Table 110. LBC Company Information Table 111. LBC Business Overview Table 112. LBC Coronary Stents Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 113. LBC Coronary Stents Product Portfolio Table 114. LBC Recent Development Table 115. Essen Technology Company Information Table 116. Essen Technology Business Overview Table 117. Essen Technology Coronary Stents Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 118. Essen Technology Coronary Stents Product Portfolio Table 119. Essen Technology Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Coronary Stents Distributors List Table 123. Coronary Stents Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Coronary Stents Product Image Figure 2. Global Coronary Stents Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coronary Stents Sales Value (2021-2032) & (US$ Million) Figure 4. Global Coronary Stents Sales (2021-2032) & (K Units) Figure 5. Global Coronary Stents Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Coronary Stents Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Bare-metal Stent (BMS) Image Figure 10. Drug-eluting Stent (DES) Image Figure 11. Bioresorbable Vascular Scaffold (BVS) Image Figure 12. Global Coronary Stents Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Coronary Stents Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Coronary Stents Sales Volume Share by Type (2021-2032) Figure 15. Global Coronary Stents Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Coronary Stents Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Coronary Stents Sales Value Share by Type (2021-2032) Figure 18. ASCs Image Figure 19. Hospitals Image Figure 20. Cardiology Center Image Figure 21. Global Coronary Stents Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Coronary Stents Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Coronary Stents Sales Volume Share by Application (2021-2032) Figure 24. Global Coronary Stents Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Coronary Stents Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Coronary Stents Sales Value Share by Application (2021-2032) Figure 27. Global Coronary Stents Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Coronary Stents Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Coronary Stents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Coronary Stents Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Coronary Stents Sales Value (2021-2032) & (US$ Million) Figure 32. North America Coronary Stents Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Coronary Stents Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Coronary Stents Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Coronary Stents Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Coronary Stents Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Coronary Stents Sales Value (2021-2032) & (US$ Million) Figure 38. South America Coronary Stents Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Coronary Stents Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Coronary Stents Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Coronary Stents Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Coronary Stents Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Bare-metal Stent (BMS)
  • Drug-eluting Stent (DES)
  • Bioresorbable Vascular Scaffold (BVS)
Applications
  • ASCs
  • Hospitals
  • Cardiology Center
Companies covered
  • Medtronic
  • Boston Scientific
  • Biosensors
  • Terumo
  • MicroPort
  • Lepu Medical
  • B.Braun
  • Atrium Medical
  • SINOMED
  • LBC
  • Essen Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Coronary Stents Sales Value (2021-2032)
  4. 1.2.2 Global Coronary Stents Sales Volume (2021-2032)
  5. 1.2.3 Global Coronary Stents Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Coronary Stents Market Dynamics
  1. 2.1 Coronary Stents Industry Trends
  2. 2.2 Coronary Stents Industry Drivers
  3. 2.3 Coronary Stents Industry Opportunities and Challenges
  4. 2.4 Coronary Stents Industry Restraints
3 Coronary Stents Market by Company
  1. 3.1 Global Coronary Stents Company Revenue Ranking in 2025
  2. 3.2 Global Coronary Stents Revenue by Company (2021-2026)
  3. 3.3 Global Coronary Stents Sales Volume by Company (2021-2026)
  4. 3.4 Global Coronary Stents Average Price by Company (2021-2026)
  5. 3.5 Global Coronary Stents Company Ranking (2024-2026)
  6. 3.6 Global Coronary Stents Company Manufacturing Base and Headquarters
  7. 3.7 Global Coronary Stents Company Product Type and Application
  8. 3.8 Global Coronary Stents Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Coronary Stents Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Coronary Stents Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Coronary Stents Market by Type
  1. 4.1 Coronary Stents Type Introduction
  2. 4.1.1 Bare-metal Stent (BMS)
  3. 4.1.2 Drug-eluting Stent (DES)
  4. 4.1.3 Bioresorbable Vascular Scaffold (BVS)
  5. 4.2 Global Coronary Stents Sales Volume by Type
  6. 4.2.1 Global Coronary Stents Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Coronary Stents Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Coronary Stents Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Coronary Stents Sales Value by Type
  10. 4.3.1 Global Coronary Stents Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Coronary Stents Sales Value by Type (2021-2032)
  12. 4.3.3 Global Coronary Stents Sales Value Share by Type (2021-2032)
5 Coronary Stents Market by Application
  1. 5.1 Coronary Stents Application Introduction
  2. 5.1.1 ASCs
  3. 5.1.2 Hospitals
  4. 5.1.3 Cardiology Center
  5. 5.2 Global Coronary Stents Sales Volume by Application
  6. 5.2.1 Global Coronary Stents Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Coronary Stents Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Coronary Stents Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Coronary Stents Sales Value by Application
  10. 5.3.1 Global Coronary Stents Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Coronary Stents Sales Value by Application (2021-2032)
  12. 5.3.3 Global Coronary Stents Sales Value Share by Application (2021-2032)
6 Coronary Stents Regional Sales and Value Analysis
  1. 6.1 Global Coronary Stents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Coronary Stents Sales by Region (2021-2032)
  3. 6.2.1 Global Coronary Stents Sales by Region: 2021-2026
  4. 6.2.2 Global Coronary Stents Sales by Region (2027-2032)
  5. 6.3 Global Coronary Stents Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Coronary Stents Sales Value by Region (2021-2032)
  7. 6.4.1 Global Coronary Stents Sales Value by Region: 2021-2026
  8. 6.4.2 Global Coronary Stents Sales Value by Region (2027-2032)
  9. 6.5 Global Coronary Stents Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Coronary Stents Sales Value (2021-2032)
  12. 6.6.2 North America Coronary Stents Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Coronary Stents Sales Value (2021-2032)
  15. 6.7.2 Europe Coronary Stents Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Coronary Stents Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Coronary Stents Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Coronary Stents Sales Value (2021-2032)
  21. 6.9.2 South America Coronary Stents Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Coronary Stents Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Coronary Stents Sales Value Share by Country, 2025 VS 2032
7 Coronary Stents Country-level Sales and Value Analysis
  1. 7.1 Global Coronary Stents Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Coronary Stents Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Coronary Stents Sales by Country (2021-2032)
  4. 7.3.1 Global Coronary Stents Sales by Country (2021-2026)
  5. 7.3.2 Global Coronary Stents Sales by Country (2027-2032)
  6. 7.4 Global Coronary Stents Sales Value by Country (2021-2032)
  7. 7.4.1 Global Coronary Stents Sales Value by Country (2021-2026)
  8. 7.4.2 Global Coronary Stents Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Coronary Stents Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Coronary Stents Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Coronary Stents Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Coronary Stents Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Coronary Stents Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Coronary Stents Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Coronary Stents Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Coronary Stents Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Coronary Stents Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Coronary Stents Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Coronary Stents Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Coronary Stents Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Coronary Stents Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Coronary Stents Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Coronary Stents Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Coronary Stents Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Coronary Stents Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Coronary Stents Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Coronary Stents Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Coronary Stents Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Coronary Stents Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Coronary Stents Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Coronary Stents Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Coronary Stents Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Coronary Stents Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Coronary Stents Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Coronary Stents Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Coronary Stents Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Coronary Stents Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Coronary Stents Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Coronary Stents Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Coronary Stents Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Coronary Stents Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Coronary Stents Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Coronary Stents Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Coronary Stents Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Coronary Stents Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Coronary Stents Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Coronary Stents Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Coronary Stents Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Coronary Stents Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Coronary Stents Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Coronary Stents Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Coronary Stents Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Coronary Stents Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Coronary Stents Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Coronary Stents Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Coronary Stents Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Coronary Stents Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Coronary Stents Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Coronary Stents Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Coronary Stents Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Coronary Stents Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Coronary Stents Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Coronary Stents Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Coronary Stents Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Coronary Stents Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Coronary Stents Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Coronary Stents Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Coronary Stents Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Coronary Stents Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Coronary Stents Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Coronary Stents Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Coronary Stents Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Coronary Stents Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Coronary Stents Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Coronary Stents Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Coronary Stents Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Coronary Stents Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Coronary Stents Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Coronary Stents Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Coronary Stents Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Coronary Stents Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Coronary Stents Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Coronary Stents Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Coronary Stents Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Coronary Stents Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Coronary Stents Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Coronary Stents Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Coronary Stents Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Coronary Stents Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Coronary Stents Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Coronary Stents Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Coronary Stents Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Coronary Stents Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Coronary Stents Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Boston Scientific
  8. 8.2.1 Boston Scientific Company Information
  9. 8.2.2 Boston Scientific Business Overview
  10. 8.2.3 Boston Scientific Coronary Stents Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Boston Scientific Coronary Stents Product Portfolio
  12. 8.2.5 Boston Scientific Recent Developments
  13. 8.3 Biosensors
  14. 8.3.1 Biosensors Company Information
  15. 8.3.2 Biosensors Business Overview
  16. 8.3.3 Biosensors Coronary Stents Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Biosensors Coronary Stents Product Portfolio
  18. 8.3.5 Biosensors Recent Developments
  19. 8.4 Terumo
  20. 8.4.1 Terumo Company Information
  21. 8.4.2 Terumo Business Overview
  22. 8.4.3 Terumo Coronary Stents Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Terumo Coronary Stents Product Portfolio
  24. 8.4.5 Terumo Recent Developments
  25. 8.5 MicroPort
  26. 8.5.1 MicroPort Company Information
  27. 8.5.2 MicroPort Business Overview
  28. 8.5.3 MicroPort Coronary Stents Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 MicroPort Coronary Stents Product Portfolio
  30. 8.5.5 MicroPort Recent Developments
  31. 8.6 Lepu Medical
  32. 8.6.1 Lepu Medical Company Information
  33. 8.6.2 Lepu Medical Business Overview
  34. 8.6.3 Lepu Medical Coronary Stents Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Lepu Medical Coronary Stents Product Portfolio
  36. 8.6.5 Lepu Medical Recent Developments
  37. 8.7 B.Braun
  38. 8.7.1 B.Braun Company Information
  39. 8.7.2 B.Braun Business Overview
  40. 8.7.3 B.Braun Coronary Stents Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 B.Braun Coronary Stents Product Portfolio
  42. 8.7.5 B.Braun Recent Developments
  43. 8.8 Atrium Medical
  44. 8.8.1 Atrium Medical Company Information
  45. 8.8.2 Atrium Medical Business Overview
  46. 8.8.3 Atrium Medical Coronary Stents Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Atrium Medical Coronary Stents Product Portfolio
  48. 8.8.5 Atrium Medical Recent Developments
  49. 8.9 SINOMED
  50. 8.9.1 SINOMED Company Information
  51. 8.9.2 SINOMED Business Overview
  52. 8.9.3 SINOMED Coronary Stents Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 SINOMED Coronary Stents Product Portfolio
  54. 8.9.5 SINOMED Recent Developments
  55. 8.10 LBC
  56. 8.10.1 LBC Company Information
  57. 8.10.2 LBC Business Overview
  58. 8.10.3 LBC Coronary Stents Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 LBC Coronary Stents Product Portfolio
  60. 8.10.5 LBC Recent Developments
  61. 8.11 Essen Technology
  62. 8.11.1 Essen Technology Company Information
  63. 8.11.2 Essen Technology Business Overview
  64. 8.11.3 Essen Technology Coronary Stents Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Essen Technology Coronary Stents Product Portfolio
  66. 8.11.5 Essen Technology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Coronary Stents Value Chain Analysis
  2. 9.1.1 Coronary Stents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Coronary Stents Sales Mode & Process
  6. 9.2 Coronary Stents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Coronary Stents Distributors
  9. 9.2.3 Coronary Stents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst